CN103060269A - 一种提取及培养间充质干细胞的方法 - Google Patents
一种提取及培养间充质干细胞的方法 Download PDFInfo
- Publication number
- CN103060269A CN103060269A CN2012104887833A CN201210488783A CN103060269A CN 103060269 A CN103060269 A CN 103060269A CN 2012104887833 A CN2012104887833 A CN 2012104887833A CN 201210488783 A CN201210488783 A CN 201210488783A CN 103060269 A CN103060269 A CN 103060269A
- Authority
- CN
- China
- Prior art keywords
- fatty tissue
- centrifugal
- cell
- substratum
- digestion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 210000002901 mesenchymal stem cell Anatomy 0.000 title abstract description 19
- 238000012258 culturing Methods 0.000 claims abstract description 28
- 210000000577 adipose tissue Anatomy 0.000 claims description 90
- 210000004027 cell Anatomy 0.000 claims description 69
- 239000007788 liquid Substances 0.000 claims description 51
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 44
- 230000029087 digestion Effects 0.000 claims description 44
- 239000002609 medium Substances 0.000 claims description 37
- 239000000872 buffer Substances 0.000 claims description 33
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 33
- 239000002953 phosphate buffered saline Substances 0.000 claims description 33
- 210000000130 stem cell Anatomy 0.000 claims description 32
- 239000006228 supernatant Substances 0.000 claims description 28
- 210000002381 plasma Anatomy 0.000 claims description 26
- 239000012535 impurity Substances 0.000 claims description 21
- 239000013049 sediment Substances 0.000 claims description 21
- 238000005406 washing Methods 0.000 claims description 20
- 238000010790 dilution Methods 0.000 claims description 19
- 239000012895 dilution Substances 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 16
- 239000008280 blood Substances 0.000 claims description 16
- 238000004321 preservation Methods 0.000 claims description 14
- 102000029816 Collagenase Human genes 0.000 claims description 13
- 108060005980 Collagenase Proteins 0.000 claims description 13
- 229960002424 collagenase Drugs 0.000 claims description 13
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 12
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 12
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 12
- 229930182566 Gentamicin Natural products 0.000 claims description 12
- 229960002518 gentamicin Drugs 0.000 claims description 12
- 230000003321 amplification Effects 0.000 claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 9
- 230000010100 anticoagulation Effects 0.000 claims description 8
- 102000012422 Collagen Type I Human genes 0.000 claims description 7
- 108010022452 Collagen Type I Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 claims description 7
- 230000002776 aggregation Effects 0.000 claims description 7
- 238000004220 aggregation Methods 0.000 claims description 7
- 239000003146 anticoagulant agent Substances 0.000 claims description 7
- 229940127219 anticoagulant drug Drugs 0.000 claims description 7
- 230000003115 biocidal effect Effects 0.000 claims description 7
- 239000006143 cell culture medium Substances 0.000 claims description 7
- 239000006285 cell suspension Substances 0.000 claims description 7
- 230000001413 cellular effect Effects 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 210000003743 erythrocyte Anatomy 0.000 claims description 7
- 229920000669 heparin Polymers 0.000 claims description 7
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 7
- 229960001008 heparin sodium Drugs 0.000 claims description 7
- 230000002035 prolonged effect Effects 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 108010019160 Pancreatin Proteins 0.000 claims description 6
- 210000004691 chief cell of stomach Anatomy 0.000 claims description 6
- 229940055695 pancreatin Drugs 0.000 claims description 6
- 150000003016 phosphoric acids Chemical class 0.000 claims description 6
- 230000001902 propagating effect Effects 0.000 claims description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 1
- 239000012091 fetal bovine serum Substances 0.000 abstract 1
- 210000004623 platelet-rich plasma Anatomy 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 17
- 230000004069 differentiation Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 5
- 238000007443 liposuction Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- 102100032912 CD44 antigen Human genes 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010004729 Phycoerythrin Proteins 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000004489 deciduous teeth Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Images
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210488783.3A CN103060269B (zh) | 2012-11-27 | 2012-11-27 | 一种提取及培养间充质干细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210488783.3A CN103060269B (zh) | 2012-11-27 | 2012-11-27 | 一种提取及培养间充质干细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103060269A true CN103060269A (zh) | 2013-04-24 |
CN103060269B CN103060269B (zh) | 2014-12-10 |
Family
ID=48103168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210488783.3A Active CN103060269B (zh) | 2012-11-27 | 2012-11-27 | 一种提取及培养间充质干细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103060269B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104974984A (zh) * | 2015-04-13 | 2015-10-14 | 深圳市默赛尔生物医学科技发展有限公司 | 一种脂肪组织来源的间充质干细胞的扩增培养方法 |
KR20160119609A (ko) * | 2015-04-06 | 2016-10-14 | 박준한 | 지방 조직으로부터 지방줄기세포를 수득하는 방법 |
CN106701673A (zh) * | 2017-01-20 | 2017-05-24 | 北京天晟宇生物科技有限公司 | 一种人羊膜间充质干细胞的专用培养基 |
CN106978396A (zh) * | 2017-05-26 | 2017-07-25 | 黎洪棉 | 一种脂肪间充质干细胞克隆的扩增培养方法 |
CN110343661A (zh) * | 2019-04-24 | 2019-10-18 | 朗姿赛尔生物科技(广州)有限公司 | 一种人体脂肪干细胞的提取及培养扩增方法 |
CN110846275A (zh) * | 2019-12-12 | 2020-02-28 | 赛瑞诺(北京)生物科技有限公司 | 一种人自体脂肪间充质干细胞的无血清培养方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101974486A (zh) * | 2010-11-25 | 2011-02-16 | 王泰华 | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
-
2012
- 2012-11-27 CN CN201210488783.3A patent/CN103060269B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101974486A (zh) * | 2010-11-25 | 2011-02-16 | 王泰华 | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
Non-Patent Citations (3)
Title |
---|
孙洁和张剑明: "富血小板血浆制备方法的研究进展", 《国际口腔医学杂志》, vol. 36, no. 5, 30 September 2009 (2009-09-30), pages 567 - 570 * |
李冬艳等: "脂肪来源的间充质干细胞分离方法的改进", 《暨南大学学报(医学版)》, vol. 28, no. 6, 31 December 2007 (2007-12-31), pages 585 - 589 * |
陈锦等: "兔脂肪来源干细胞分离培养及富血小板血浆对其增殖的影响", 《中国美容整形外科杂志》, vol. 22, no. 1, 31 January 2011 (2011-01-31), pages 53 - 57 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160119609A (ko) * | 2015-04-06 | 2016-10-14 | 박준한 | 지방 조직으로부터 지방줄기세포를 수득하는 방법 |
KR101719743B1 (ko) * | 2015-04-06 | 2017-03-24 | 박준한 | 지방 조직으로부터 지방줄기세포를 수득하는 방법 |
CN104974984A (zh) * | 2015-04-13 | 2015-10-14 | 深圳市默赛尔生物医学科技发展有限公司 | 一种脂肪组织来源的间充质干细胞的扩增培养方法 |
CN106701673A (zh) * | 2017-01-20 | 2017-05-24 | 北京天晟宇生物科技有限公司 | 一种人羊膜间充质干细胞的专用培养基 |
CN106978396A (zh) * | 2017-05-26 | 2017-07-25 | 黎洪棉 | 一种脂肪间充质干细胞克隆的扩增培养方法 |
CN110343661A (zh) * | 2019-04-24 | 2019-10-18 | 朗姿赛尔生物科技(广州)有限公司 | 一种人体脂肪干细胞的提取及培养扩增方法 |
CN110343661B (zh) * | 2019-04-24 | 2021-08-24 | 朗姿赛尔生物科技(广州)有限公司 | 一种人体脂肪干细胞的提取及培养扩增方法 |
CN110846275A (zh) * | 2019-12-12 | 2020-02-28 | 赛瑞诺(北京)生物科技有限公司 | 一种人自体脂肪间充质干细胞的无血清培养方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103060269B (zh) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103060269B (zh) | 一种提取及培养间充质干细胞的方法 | |
CN104263697B (zh) | 一种诱导培养基及诱导人脂肪间充质干细胞生成胰岛素分泌细胞的方法 | |
CN102127522B (zh) | 人脐带间充质干细胞及其制备方法 | |
CN103667182B (zh) | 一种骨髓间充质干细胞在体外向成骨细胞分化的诱导方法及诱导培养基 | |
CN103070161B (zh) | 一种脂肪间充质干细胞冻存液及冻存方法 | |
CN103266081B (zh) | 从脐带中分离培养间充质干细胞的高效方法 | |
CN102676451B (zh) | 从胎盘中分离间充质干细胞的方法 | |
CN104450611B (zh) | 一种人羊膜间充质干细胞原代分离及培养方法 | |
CN107236704A (zh) | 从胎盘分离间充质干细胞的方法和使用的消化酶组合物 | |
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
CN102978156A (zh) | 一种骨髓间充质干细胞的体外扩增纯化培养方法及培养基 | |
CN104974984A (zh) | 一种脂肪组织来源的间充质干细胞的扩增培养方法 | |
CN1912109B (zh) | 一种组织工程化脂肪组织的构建方法与应用 | |
CN101974486A (zh) | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 | |
CN102965337A (zh) | 分离提取人皮下脂肪间充质干细胞的方法和提取专用培养基 | |
CN103305461B (zh) | 一种以月经产物制备间充质干细胞的方法 | |
CN108795855A (zh) | 一种间充质干细胞的无血清培养基 | |
CN110438072A (zh) | 脂肪间充质干细胞的制备方法 | |
CN105219707A (zh) | 一种复苏脂肪间充质干细胞的方法 | |
CN106318906A (zh) | 一种大规模培养人脐带间充质干细胞的方法 | |
CN104651305A (zh) | 一种利用脐带间充质干细胞获取生物活性蛋白的方法 | |
CN108486050A (zh) | 从犬的脐带制备间充质干细胞的方法 | |
CN1778905B (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN102965338A (zh) | 人脐带间充质干细胞的提取和培养方法 | |
CN106635971A (zh) | 一种自体软骨细胞的原代分离方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Taihua Inventor after: Li Rongrong Inventor before: Wang Taihua Inventor before: Li Rongrong Inventor before: Sun Tao |
|
CB03 | Change of inventor or designer information |
Inventor after: Wang Taihua Inventor after: Li Rongrong Inventor before: Wang Taihua Inventor before: Li Rongrong Inventor before: Sun Tao |
|
CB03 | Change of inventor or designer information | ||
DD01 | Delivery of document by public notice |
Addressee: SHANDONG NEW MEDICINE RESEARCH INSTITUTE OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE LLC Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231227 Address after: Room 401, Building 10, No. 6 Hongmian Road, Songshanhu Park, Dongguan City, Guangdong Province, 523425 Patentee after: Guangdong cel Biotechnology Co.,Ltd. Address before: Room 603, Pilot Plant Building, No. 978 Tianchen Street, High tech Development Zone, Jinan City, Shandong Province, 250100 Patentee before: SHANDONG NEW MEDICINE RESEARCH INSTITUTE OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE LLC |
|
TR01 | Transfer of patent right |